6 Matching Annotations
  1. Last 7 days
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13269783/
  3. Mar 2025
  4. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11927390/
  5. Oct 2024
  6. aacrjournals.org aacrjournals.org
    NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerimmunolres/article/12/10/1421/748722/NK-Receptor-Signaling-Lowers-TCR-Activation
  7. Jun 2023
  8. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    A genetically engineered, stem-cell-derived cellular vaccine
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9727836/
  9. Dec 2022
  10. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    A genetically engineered, stem-cell-derived cellular vaccine
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9727836/
  11. Jun 2021
  12. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8193615/